The proposed legislation to repeal the Medicare sustainable growth rate (SGR), the method currently used to compensate participating physicians, would mean significant change for the Meaningful Use ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being evaluated in a Phase 1 dose-escalation study ...

CEO Ramy Farid highlighted "very solid progress in the first half of 2025" with total revenue of $54.8 million in the second quarter, a 16% increase year-over-year. Software revenue reached $40.5 ...

Editor’s Note: This is the fifth post in a Health Affairs Blog series on Medicare physician compensation and the Sustainable Growth Rate mechanism. Paul Ginsburg, Robert Berenson, Mina Matin, and Jay ...